MoneyWorks4Me

The company's total revenue for the quarter ended December 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 1306.00 millions.Profit after tax for the quarter ended December 2022 reported a huge growth of 51.25% to Rs. 591.70  millions from Rs. 391.20 millions.The company reported a good operating profit of 808.70 millions compared to 620.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1306.00 1282.20 1.86 3839.40 4161.20 -7.73 5280.60 4826.80 9.40
Other Income 293.60 85.40 243.79 867.80 462.90 87.47 565.50 186.20 203.71
PBIDT 808.70 620.20 30.39 2418.20 2274.80 6.30 2761.70 2325.50 18.76
Interest 0.40 0.20 100.00 0.90 0.70 28.57 0.90 1.70 -47.06
PBDT 808.30 620.00 30.37 2417.30 2274.10 6.30 2760.80 2323.80 18.81
Depreciation 64.70 63.10 2.54 193.50 188.20 2.82 257.70 224.40 14.84
PBT 743.60 556.90 33.52 2223.80 2085.90 6.61 2503.10 2099.40 19.23
TAX 151.90 165.70 -8.33 424.60 497.60 -14.67 624.40 537.10 16.25
Deferred Tax -16.60 3.00 -653.33 -61.70 8.10 -861.73 8.20 -11.70 -170.09
PAT 591.70 391.20 51.25 1799.20 1588.30 13.28 1878.70 1562.30 20.25
Equity 151.80 151.50 0.20 151.80 151.50 0.20 151.60 151.30 0.20
PBIDTM(%) 61.92 48.37 28.02 62.98 54.67 15.21 52.30 48.18 8.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..